• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Assure Holdings Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    7/24/24 8:15:09 AM ET
    $IONM
    Medical/Dental Instruments
    Health Care
    Get the next $IONM alert in real time by email
    false 0001798270 0001798270 2024-07-18 2024-07-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of report (Date of earliest event reported): July 18, 2024

     

    Assure Holdings Corp.

    (Exact name of registrant as specified in its charter)

     

    Nevada   001-40785   82-2726719
    (State or other jurisdiction
    of incorporation)
      (Commission
    File Number)
      (IRS Employer
    Identification No.)

     

    7887 East Belleview Avenue, Suite 240
    Denver, CO
      80111
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: 720-287-3093

     

    _____________________________________________

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, par value $0.001 per share   IONM   NASDAQ Capital Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

     

    Emerging growth company x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

     

    Item 1.01. Entry into a Material Definitive Agreement.

     

    Memorandum of Understanding – Settlement of Debenture and Security Documents

     

    On July 18, 2024, Assure Holdings Corp. (the “Company” or “Assure”) entered into a binding memorandum of understanding (the “MOU”) with Centurion Financial Trust, an investment trust formed by Centurion Asset Management Inc. (“Centurion”) pursuant to which the Company and Centurion agreed to the settlement of the Company’s obligations under that certain debenture issued on June 9, 2021 (the “Debenture”) to Centurion, acting on behalf of the lenders thereunder, from time to time (the “Lender”), with a maturity date of June 9, 2025 (the “Maturity Date”), in the principal amount of $11 million related to a credit facility comprised of a $6 million senior term loan (the “Senior Term Loan”), a $2 million senior revolving loan (the “Senior Revolving Loan”) and a $3 million senior term acquisition line (the “Senior Term Acquisition Line” and together with the Senior Term Loan and the Senior Revolving Loan, the “Credit Facility”). The Debenture and the Credit Facility issued pursuant to the terms of a commitment letter dated March 8, 2021 (the “Commitment Letter”).

     

    The Debenture is secured by Centurion’s security interests under that certain General Security Agreement dated June 9, 2021 (the “Security Agreement”) with Centurion, pursuant to which, among other things, the Company and the subsidiaries named therein granted Centurion, in its capacity as agent and nominee to the Lender, a first priority security interest (the “Security Interest”) on all of the assets of the Company and the subsidiaries, respectively, defined as “Collateral” under the Security Agreement (the “Collateral”) and to all “Intellectual Property” (as defined in the Security Agreement, the “Intellectual Property”) of the Company and the subsidiaries. As a further security for the repayment of the Company’s obligations, the subsidiaries of the Company entered into a Guarantee and Indemnity Agreement dated June 9, 2021 (the “Guarantee”, together with the Security Agreement, the “) with the Agent, as lender and as agent and nominee for certain lenders pursuant to the Debenture, pursuant to which the Subsidiaries irrevocably and unconditionally guaranteed to the Agent, as a continuing obligation, the full and punctual payment and performance of the Obligations when due, whether at stated maturity, by acceleration, declaration, demand, or otherwise

     

    Under the MOU, the Company and Centurion agreed to settle the Company’s obligations under the Debenture in accordance with (i) the assignment of certain assets of the Company to Centurion, as set forth below (the “Assigned Assets”), (ii) the exchange of the remaining amount of obligation under the Debenture into shares of common stock, par value $0.001 (the “Exchange Common Stock”) at a price of $4.11 per share, and (iii) the payment of an accommodation fee of $750,000 to Centurion by the Company to be paid in shares of common stock the same price as the Exchange Common Stock, as set forth in (ii) above (the “Additional Stock”)(the Exchange Common Stock and the Additional Stock are the “Settlement Common Stock”).

     

    The Company also agreed to pay to Centurion a cash payment as follows: If between the date of the MOU and July 22, 2024, the Company closed a public or private offering of the Company’s equity securities for cash, with aggregate gross proceeds to the Company of at least $8.0 million, then within 5 business days of the closing of such offering, the Company would pay to Centurion fifty percent of the net proceeds in excess of $8 million in cash and reduce the Settlement Common Stock by the equal dollar amount (the “Cash Payment”). The Company did not close an offering through July 22, 2023 and no Cash Payment was due or paid.

     

    The Assigned Assets under the MOU are as follows:

     

    (a)$2.5 million of the Company’s federal and state settlements and IDR Awards under the “No Suprises Act” (the “IDR Accounts Receivable”), which the parties agreed have a stated value of $2.5 million. Centurion shall be entitled to cash receipts from the assigned IDR Accounts Receivable equal to an aggregate of $2.5 million and the Company will retain rights to all cash receipts from the assigned IDR Accounts Receivable in excess of $2.5 million.

     

     

     

     

    (b)$3.0 million of the Company’s Employee Retention Tax Credit refund from the Internal Revenue Service from the tax years 2020 through 2021, which the parties agreed will have a stated value of $3.0 million.

     

    At the closing under the MOU, the Company will issue the Additional Stock (as disclosed above) and, following the reduction of the obligations for any Cash Payment and the value of the Assigned Assets, the portion of the obligations under the Debenture that remain outstanding (the “Conversion Amount”), will be exchanged into the number of Exchange Shares equal to the quotient of (A) the Conversion Amount divided by $4.11 (the “Exchange”). The number of shares of Settlement Common Stock is subject to being held in abeyance if the percentage ownership of the Company held by Centurion would exceed 9.99% of the issued and outstanding shares then outstanding. In lieu of such shares of Settlement Common Stock, Centurion will receive a right to abeyance shares, which right will remain subject to the same ownership restriction, and the shares issuable thereunder will be issued from time to time to Centurion to the extent that such shares will not result in Centurion, at any time, owning over 9.99% of the Company’s issued and outstanding shares of common stock.

     

    Under the MOU, Centurion has agreed that the assignment of the Assigned Assets and the issuance of the Settlement Common Stock constitutes complete satisfaction of the obligations under the Debenture and that at the closing, the obligations shall be deemed to have been paid in full and indefeasibly discharged by the assignment and stock issuance with no further obligations existing under the Debenture and the Debenture shall be extinguished and canceled in its entirety and Centurion will then release and forever discharge the Company and the subsidiaries of the Company, of and from any and all past, present or future claims, demands, obligations, actions, causes of action, rights, damages, costs, loss of services, expenses and compensation which Centurion now has, or which may hereafter accrue or otherwise be acquired, on account of, or in any way growing out of the Debenture, the Security Agreement and the Guarantee (the “Settlement”).

     

    Upon the closing under the MOU, Centurion will issue to the Company a release and cancellation of the Debenture, the Security Documents and Centurion’s Security Interests and guarantee under the Security Documents.

     

    Under the MOU, the Company acknowledged that it may be in default under certain of the covenants and provisions of the Debenture and the Security Documents (collectively, the “Loan Documents”), pursuant to which the Lender has the right to accelerate its obligations under the Loan Documents. In consideration of the settlement terms in the MOU, from the date of the MOU until July 23, 2024, the Lender agreed to forbear in the exercise of any rights or remedies, whether granted in Loan Documents or under law, with respect to the Company or any of its assets (the “Forbearance Period”), other than the exercise of the Permitted Remedies. As used in the MOU, the “Permitted Remedies” shall be limited solely to (i) enforce the terms of the MOU and (ii) to obtain the benefits of the continuing indemnification obligations of the Company to Lenders in the Loan Documents. The Forbearance Period terminated automatically upon the occurrence of any of the following events: (i) the commencement by the Company or any its subsidiaries of a voluntary proceeding seeking relief with respect to itself or its debts under any bankruptcy, insolvency or similar law, or seeking appointment of a trustee, receiver, liquidator or other similar official for it or any substantial part of its assets; or its consent to any of the foregoing in any involuntary proceeding against it; or makes an assignment for the benefit of, or the offering to or entering into by. The Company or any of its Subsidiaries of any reorganization with its creditors, (ii) commencement of an involuntary proceeding against the Company or any of its subsidiaries of the kind described in clause (i) above.

     

    Centurion also agreed to the cancellation of all of its common stock purchase warrants of the Company.

     

    The above is a summary of the material terms of the MOU is qualified in its entirety by the full terms and conditions of the MOU, which is filed as Exhibit 10.1 to this Current Report on Form 8-K, and which is incorporated by reference herein.

     

    Item 9.01. Financial Statements and Exhibits

     

    (d) Exhibits.

     

    Exhibit No.   Name
    10.1    Memorandum of Understanding with Centurion Financial Trust dated July 18, 2024
    104   Cover Page Interactive Data File (formatted in Inline XBRL and included as Exhibit 101).

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirement of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

     

      ASSURE HOLDINGS CORP.
         
    Date: July 24, 2024 By: /s/ John Farlinger
      Name: John Farlinger
      Title: Chief Executive Officer

     

     

     

    Get the next $IONM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IONM

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $IONM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Assure Announces Amendment of Exchange Offer Relating to its Convertible Notes

    Assure Holdings Corp. ("Assure" or the "Company") (OTC:IONM), today announced that it has amended the Convertible Note Exchange Offer of June 21, 2024, relating to the Company's 9% Convertible Debentures due in 2023 and 2024 (the "Assure Convertible Debentures"). This ninth amendment further amends and restates certain sections of the Convertible Note Exchange Offer ("Amended Offer Letter") as follows: (i) updates the Amended Offer Letter to reflect a change in the consideration being offered for each $1,000 claim from 238.44 shares of common stock consisting of principal amount, and accrued and unpaid interest through, and including, July 19, 2024 to 1,000 shares of common stock consisting

    9/6/24 8:45:00 PM ET
    $IONM
    Medical/Dental Instruments
    Health Care

    Assure Announces Further Extension of Exchange Offer Relating to its Convertible Notes

    DENVER, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. ("Assure" or the "Company") (OTC:IONM), today announced that it has extended the expiration date of its exchange offer (the "Offer") relating to the Company's 9% Convertible Debentures due 2023 and 2024 (the "Assure Convertible Debentures"). As a result of the extension, the Exchange Offer is now scheduled to expire at 11:59 p.m. (Denver Time), on September 6, 2024 (the "Expiration Date") unless further extended. The Offer was originally scheduled to expire at 11:59 p.m. (Denver Time) on July 19, 2024, and has been extended several times to now expire at 11:59 p.m. (Denver Time), on September 6, 2024. Except for the extension

    8/26/24 8:00:00 AM ET
    $IONM
    Medical/Dental Instruments
    Health Care

    Assure Announces Further Extension of Exchange Offer Relating to its Convertible Notes

    DENVER, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. ("Assure" or the "Company") (OTC:IONM), today announced that it has extended the expiration date of its exchange offer (the "Offer") relating to the Company's 9% Convertible Debentures due 2023 and 2024 (the "Assure Convertible Debentures"). As a result of the extension, the Exchange Offer is now scheduled to expire at 11:59 p.m. (Denver Time), on August 23, 2024 (the "Expiration Date") unless further extended. The Offer was originally scheduled to expire at 11:59 p.m. (Denver Time) on July 19, 2024, and has been extended several times to now expire at 11:59 p.m. (Denver Time), on August 23, 2024. Except for the extension of

    8/19/24 8:00:00 AM ET
    $IONM
    Medical/Dental Instruments
    Health Care

    $IONM
    SEC Filings

    View All

    Assure Holdings Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Assure Holdings Corp. (0001798270) (Filer)

    1/22/25 4:00:28 PM ET
    $IONM
    Medical/Dental Instruments
    Health Care

    Assure Holdings Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Assure Holdings Corp. (0001798270) (Filer)

    12/23/24 4:01:32 PM ET
    $IONM
    Medical/Dental Instruments
    Health Care

    SEC Form NT 10-Q filed by Assure Holdings Corp.

    NT 10-Q - Assure Holdings Corp. (0001798270) (Filer)

    11/15/24 7:19:43 PM ET
    $IONM
    Medical/Dental Instruments
    Health Care

    $IONM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Parsons Preston T

    4 - Assure Holdings Corp. (0001798270) (Issuer)

    4/13/23 8:43:47 PM ET
    $IONM
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Burian Martin Andrew

    4 - Assure Holdings Corp. (0001798270) (Issuer)

    4/10/23 7:31:27 PM ET
    $IONM
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Parsons Preston T

    4 - Assure Holdings Corp. (0001798270) (Issuer)

    4/10/23 4:41:09 PM ET
    $IONM
    Medical/Dental Instruments
    Health Care

    $IONM
    Financials

    Live finance-specific insights

    View All

    Assure & Danam Reschedule Corporate Update Call & Webcast

    DENVER, May 17, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced today that management has rescheduled the joint corporate update call with Danam for Wednesday, May 22, 2024 at 4:00 PM Eastern Time. Conference Call InformationDate: Wednesday, May 22, 2024Time: 4:00 PM Eastern TimeToll Free: 1-877-545-0523International: 1-973-528-0016Participant Access Code: 229289Webcast Link: https://www.webcaster4.com/Webcast/Page/2566/50637 Conference Call Replay InformationToll Free:   1-877-481-4010International: 1-919-882-2331Replay Passcode: 50637Webcast Replay: h

    5/17/24 2:04:20 PM ET
    $IONM
    Medical/Dental Instruments
    Health Care

    Assure & Danam Postpone Corporate Update Call & Webcast Scheduled for May 16

    DENVER, May 15, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced today that the joint corporate update call with Danam scheduled for Thursday, May 16, 2024 at 4 p.m. Eastern Time has been postponed. The Company plans to reschedule the conference call at a later date. About Assure Holdings Assure Holdings Corp. is a best-in-class provider of outsourced intraoperative neuromonitoring and remote neurology services. The Company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive proc

    5/15/24 8:50:44 PM ET
    $IONM
    Medical/Dental Instruments
    Health Care

    Assure & Danam to Host Corporate Update Call & Webcast

    DENVER, May 13, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced today that management will host a joint corporate update call with Danam on Thursday, May 16, 2024 at 4:00 PM Eastern Time to provide a corporate update. Conference Call InformationDate: Thursday, May 16, 2024Time: 4:00 PM Eastern TimeToll Free: 877-545-0523International: 973-528-0016Participant Access Code: 229289Webcast Link: https://www.webcaster4.com/Webcast/Page/2566/50637 Conference Call Replay InformationToll Free: 877-481-4010International: 919-882-2331Replay Passcode: 50637Webc

    5/13/24 4:01:00 PM ET
    $IONM
    Medical/Dental Instruments
    Health Care

    $IONM
    Leadership Updates

    Live Leadership Updates

    View All

    Assure Holdings Announces Results of Annual General Meeting of Shareholders

    DENVER, Dec. 30, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced today that it held its annual general meeting of shareholders on December 28, 2022 (the "Meeting") and that all matters submitted to the shareholders of the Company for approval as set out in the Company's definitive proxy statement dated December 2, 2022 (the "Proxy Statement"), were approved by the requisite majority of votes cast at the Meeting, including: Electing the following nominees to the board of directors of the Company to serve until the Company's next annual general meeting of

    12/30/22 4:02:00 PM ET
    $IONM
    Medical/Dental Instruments
    Health Care

    Assure Holdings Further Strengthens Business Development Team with Hiring of Robynn Sweet as Vice President, Strategic Accounts

    DENVER, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced the appointment of Robynn Sweet to the position of vice president, strategic accounts. Prior to joining Assure, Ms. Sweet worked at Premier, Inc. serving as director of Group Purchasing Organization ("GPO") sales for national accounts. Before that, Ms. Sweet was regional vice president of sales at HealthTrust where her efforts were instrumental in driving more than $100 million in corporate revenue. Ms. Sweet earned a Bachelor of Science in Nursing from the University of Texas Health Scienc

    8/23/22 4:30:00 PM ET
    $IONM
    Medical/Dental Instruments
    Health Care

    Assure Holdings Further Strengthens Clinical Team with Hiring of James Watt as National Technologist Director

    DENVER, April 26, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced the appointment of James Watt to the position of national technologist director. Mr. Watt reports to Assure's vice president of clinical operations, Stephanie Krouse. In his new role, Mr. Watt leads day-to-day operations for Assure's clinical technologist team, ensuring quality of service and overseeing the Company's training and development program. In addition, Mr. Watt will play an important role in the establishment of new competencies that will drive Assure's expansion into adjacent m

    4/26/22 8:30:00 AM ET
    $IONM
    Medical/Dental Instruments
    Health Care

    $IONM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Assure Holdings Corp. (Amendment)

    SC 13G/A - Assure Holdings Corp. (0001798270) (Subject)

    2/9/24 10:14:47 AM ET
    $IONM
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Assure Holdings Corp. (Amendment)

    SC 13G/A - Assure Holdings Corp. (0001798270) (Subject)

    2/10/23 3:08:00 PM ET
    $IONM
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Assure Holdings Corp. (Amendment)

    SC 13G/A - Assure Holdings Corp. (0001798270) (Subject)

    1/10/23 4:45:27 PM ET
    $IONM
    Medical/Dental Instruments
    Health Care